![](/img/cover-not-exists.png)
Circulating heparan sulfate chains and body weight contribute to anti-Xa levels in cancer patients using the prophylactic dose of enoxaparin
Maurice-Dror, Corinne, Litvak, Michael, Keren-Politansky, Anat, Ackerman, Shanny, Haim, Nissim, Nadir, YonaJournal:
Journal of Thrombosis and Thrombolysis
DOI:
10.1007/s11239-020-02128-1
Date:
May, 2020
File:
PDF, 997 KB
2020